research use only

Rofapitide tetraxetan

Cat.No.P1275

Rofapitide tetraxetan (FAP-2286) is a potent and selective FAP-binding peptidic macrocycle conjugated to the radionuclide chelator DOTA, with a mean IC50 of 2.7 nM for binding to FAP. Rofapitide tetraxetan can be radiolabeled for imaging (⁶⁸Ga, ¹¹¹In) or therapy (¹⁷⁷Lu). ¹⁷⁷Lu-FAP-2286 shows antitumor activity in FAP-expressing tumor models.
Rofapitide tetraxetan Chemical Structure

CAS No. 2581741-18-4

Quality Control

Batch: P127501 DMSO] 100 mg/mL] false] Water] 100 mg/mL] false] Ethanol] 3 mg/mL] false Purity: 96.11%
96.11

Chemical Information & Solubility

Storage (From the date of receipt)

In vitro
Batch:

DMSO : 100 mg/mL (67.99 mM);
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 100 mg/mL

Ethanol : 3 mg/mL


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Biological Activity

Description Rofapitide tetraxetan (FAP-2286) is a potent and selective FAP-binding peptidic macrocycle conjugated to the radionuclide chelator DOTA, with a mean IC50 of 2.7 nM for binding to FAP. Rofapitide tetraxetan can be radiolabeled for imaging (⁶⁸Ga, ¹¹¹In) or therapy (¹⁷⁷Lu). ¹⁷⁷Lu-FAP-2286 shows antitumor activity in FAP-expressing tumor models.

References

  • https://aacrjournals.org/cancerres/article/82/12_Supplement/3317/701437
  • https://pubmed.ncbi.nlm.nih.gov/34168013/

Product Information

Molecular Formula

C67H99N13O18S3

Molecular Weight 1470.78
CAS No. 2581741-18-4
Storage
(From the date of receipt)
3 years-20°C(in the dark) powder
Shipping Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Read more about